# Castle Biosciences Inc: Form 8-K, filed Jul 30, 2026

- Company: [Castle Biosciences Inc](/companies/cstl.md) (CIK 1447362)
- Form: 8-K
- Filed: 2026-07-30
- Accepted by EDGAR: Jul 30, 2026, 16:06 ET
- Period: 2026-07-30
- Accession: 0001628280-26-051045
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1447362/000162828026051045/cstl-20260730.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1447362/000162828026051045/

## Items reported

- Item 2.02: Results of operations
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1447362/000162828026051045/cstl-20260730.htm

Filed Jul 30, 2026.
Source: SEC EDGAR, the filing index for accession 0001628280-26-051045. Last ingested by Listed: Oct 30, 2026, 16:13 ET. No prices; not investment advice.